← FDA Drug Approvals (Drugs@FDA)

ULORIC

NDA · New Drug Application · Sponsor: TAKEDA PHARMS USA · Approved 2009-02-13

Drug application

FDA Application #

NDA021856

Application type

New Drug Application

Brand name

ULORIC

Generic name

FEBUXOSTAT

Active ingredients

FEBUXOSTAT

Dosage form

TABLET

Route

ORAL

Marketing status

Prescription

Sponsor

TAKEDA PHARMS USA

Manufacturer

Takeda Pharmaceuticals America, Inc.

First approval

2009-02-13

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown